Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease

BACKGROUND: The statin treatment of dyslipidemia is associated with a reduced risk of development of Alzheimer disease (AD). The effect may be mediated by a reduction in cholesterol biosynthesis in the brain, by lowering levels of apolipoprotein E (apo E)-containing lipoproteins, or by pleitropic ef...

Full description

Bibliographic Details
Published in:Archives of neurology, Vol. 60, No. 4 (2003), p. 510-5
Main Author: Vega, Gloria Lena (Author)
Other Involved Persons: Weiner, Myron F ; Lipton, Anne M ; Von Bergmann, Klaus ; Lutjohann, Dieter ; Moore, Carol ; Svetlik, Doris
Format: Article
Item Description:Date Completed 07.05.2003
Date Revised 24.11.2016
published: Print
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
QR Code: Show QR Code